{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T03:38:00Z","timestamp":1782445080018,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jinf.2022.09.002","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T11:23:42Z","timestamp":1662636222000},"page":"702-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6458-463X","authenticated-orcid":false,"given":"Jameel M.","family":"Abduljalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4600-6240","authenticated-orcid":false,"given":"Abdo A.","family":"Elfiky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2022.09.002_bib0001","article-title":"Monkeypox outbreak in Madrid (Spain): clinical and virological aspects","author":"Eva","year":"2022","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.jinf.2022.09.002_bib0002","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings","volume":"61","author":"Jerome","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"suppl_2","key":"10.1016\/j.jinf.2022.09.002_bib0003","doi-asserted-by":"crossref","first-page":"W375","DOI":"10.1093\/nar\/gkm216","article-title":"MolProbity: all-atom contacts and structure validation for proteins and nucleic acids","volume":"35","author":"Davis Ian","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jinf.2022.09.002_bib0004","first-page":"19","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"James","year":"2015","journal-title":"SoftwareX"},{"issue":"2","key":"10.1016\/j.jinf.2022.09.002_bib0005","first-page":"146","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Xuan-Yu","year":"2012","journal-title":"Curr Comput Aided Drug Des"},{"issue":"2","key":"10.1016\/j.jinf.2022.09.002_bib0006","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/hep.27488","article-title":"Cardiac dysfunction associated with a nucleotide polymerase inhibitor for treatment of hepatitis C","volume":"62","author":"Tariq","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jinf.2022.09.002_bib0007","unstructured":"ClinicalTrials.gov. Study to evaluate the antiviral activity, clinical outcomes, safety, tolerability, and pharmacokinetics of orally administered lumicitabine regimens in adult participants hospitalized with respiratory syncytial virus - study results - ClinicalTrials.gov. Available at https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02935673. Accessed September 10, 2022."}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322005321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322005321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:35:39Z","timestamp":1759008939000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322005321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0163445322005321"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.09.002","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}